Yugoslavia
SYMPOSIUM: OBJECTIVES
IN MEDICINE
December 3, 2002.
School of Medicine, University of Belgrade
TOPIC: BIOLOGICAL THERAPY FOR INTESTINAL
INFLAMMATORY DISEASES
Moderator: Janković G.
LECTURES:
CLINICAL PATHOPHYSIOLOGY OF BIOLOGICAL
THERAPY – Janković G.
ANTI – TNF-a
- MONOCLONAL ANTIBODIES – Milosavljević T.
-Himeric - infliximab
-Human - CDP571
ANTI – TNF-a
– OTHER INHIBITION METHODS – Tarabar D.
-Receptors (etanercept, onercept)
-Inhibition of gene expression (MAPk inhibitors, anti-NF-kappaB)
-Anti-mRNK (Thalidomide, etc.)
DRUGS EXHIBITING ACTION ON CD4 Th
Ly DIFFERENTIATION – Jojić NJ.
-IL-10
-Antibodies to interferon-g, Ifn-g
-Antibodies to IL-2R, IL-12, IL-18
DRUGS EXHIBITING ACTION ON LYMPHOCYTES
TRANSFER - Perišić V.
(access through adhesion molecules – integrins, selectins, etc.)
-Antibodies to integrins (Natalizumab, LDP-2)
-Antisense ICAM-1 (ISIS 2302))
BIOLOGICAL THERAPY – MIXED GROUP
- Krstić M.
-Interferons a and b-1a
-IL-11
-Stimulators of granulocyte colonies (Filgrastim, Sargramostim)
BIOLOGICAL THERAPY – MIXED GROUP
- Milinić N.
-Antibodies to CD4 and CD40L
-Growth factors (TGF-b, EGF, KGF)
-Growth hormone
Switzerland
TOPIC: Medicine and Surgery in Hepatology
and Gastroenterology
Decembar 6-7, 2002
Venue: Genéve
Organizer: Prof. H. Hadengue, Hospital Cantonal, Gastroenterolgie
& Hepatologie
Address: 24, rue Micheli-du-Crest
Tel. +41 (022) 372-9340
Fax +41 (022) 372-9366
|